Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.

RATIONALE Unrecognized airway infection and inflammation in young children with cystic fibrosis (CF) may lead to irreversible lung disease; therefore early detection and treatment is highly desirable. OBJECTIVES To determine whether the lung clearance index (LCI) is a sensitive and repeatable noninvasive measure of airway infection and inflammation in newborn-screened children with CF. METHODS Forty-seven well children with CF (mean age, 1.55 yr) and 25 healthy children (mean age, 1.26 yr) underwent multiple-breath washout testing. LCI within and between-test variability was assessed. Children with CF also had surveillance bronchoalveolar lavage performed. MEASUREMENTS AND MAIN RESULTS The mean (SD) LCI in healthy children was 6.45 (0.49). The LCI was higher in children with CF (7.21 [0.81]; P < 0.001). The upper limit of normal for the LCI was 7.41. Fifteen (32%) children with CF had an elevated LCI. LCI measurements were repeatable and reproducible. Airway infection was present in 17 (36%) children with CF, including 7 (15%) with Pseudomonas aeruginosa. Polymicrobial growth was associated with worse inflammation. The LCI was higher in children with Pseudomonas (7.92 [1.16]) than in children without Pseudomonas (7.02 [0.56]) (P = 0.038). The LCI correlated with bronchoalveolar lavage IL-8 (R(2) = 0.20, P = 0.004) and neutrophil count (R(2) = 0.21, P = 0.001). An LCI below the upper limit of normality had a high negative predictive value (93%) in excluding Pseudomonas. CONCLUSIONS The LCI is elevated early in CF, especially in the presence of Pseudomonas and airway inflammation. The LCI is a feasible, repeatable, and sensitive noninvasive marker of lung disease in young children with CF.

[1]  Kyle Bittinger,et al.  Topographical continuity of bacterial populations in the healthy human respiratory tract. , 2011, American journal of respiratory and critical care medicine.

[2]  P. Sly,et al.  Air Trapping on Chest CT Is Associated with Worse Ventilation Distribution in Infants with Cystic Fibrosis Diagnosed following Newborn Screening , 2011, PloS one.

[3]  J. Carlin,et al.  Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. , 2011, JAMA.

[4]  P. Sly,et al.  Infection, inflammation, and lung function decline in infants with cystic fibrosis. , 2011, American journal of respiratory and critical care medicine.

[5]  P. Sly,et al.  Exciting new clinical trials in cystic fibrosis: infants need not apply. , 2011, American journal of respiratory and critical care medicine.

[6]  J. Stocks,et al.  Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash? , 2011, European Respiratory Journal.

[7]  S. Stanojevic,et al.  Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF , 2011, Thorax.

[8]  P. Sly,et al.  Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis , 2011, Thorax.

[9]  M. Rosenfeld,et al.  Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. , 2010, American journal of respiratory and critical care medicine.

[10]  W. Lenney,et al.  Bronchoalveolar lavage in children with cystic fibrosis: how many lobes should be sampled? , 2010, Archives of Disease in Childhood.

[11]  P. Sly,et al.  Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis , 2010, Thorax.

[12]  S. Schulzke,et al.  Lung volume and ventilation inhomogeneity in preterm infants at 15-18 months corrected age. , 2010, The Journal of pediatrics.

[13]  M. Gappa,et al.  Lung clearance index: Normal values, repeatability, and reproducibility in healthy children and adolescents , 2009, Pediatric pulmonology.

[14]  P. Sly,et al.  Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. , 2009, The Journal of pediatrics.

[15]  P. Sly,et al.  Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. , 2009, American journal of respiratory and critical care medicine.

[16]  P. Sly,et al.  Lung function in infants with cystic fibrosis diagnosed by newborn screening. , 2008, American journal of respiratory and critical care medicine.

[17]  I. Masters,et al.  Safety of bronchoalveolar lavage in young children with cystic fibrosis , 2008, Pediatric pulmonology.

[18]  P. Sly,et al.  Disease surveillance using bronchoalveolar lavage. , 2008, Paediatric respiratory reviews.

[19]  P. Sly.  Early detection of lung disease in CF: do we have the necessary techniques? , 2008, Paediatric respiratory reviews.

[20]  M. Gappa,et al.  A novel sidestream ultrasonic flow sensor for multiple breath washout in children , 2008, Pediatric pulmonology.

[21]  D. Porteous,et al.  Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis , 2007, Thorax.

[22]  C. K. van der Ent,et al.  Radiological and functional changes over 3 years in young children with cystic fibrosis , 2007, European Respiratory Journal.

[23]  M. Rosenfeld,et al.  Endpoints for clinical trials in young children with cystic fibrosis. , 2007, Proceedings of the American Thoracic Society.

[24]  Janet Stocks,et al.  An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. , 2007, American journal of respiratory and critical care medicine.

[25]  B. Yankaskas,et al.  Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[26]  A. Wade,et al.  Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests , 2007, Thorax.

[27]  Mary Ellen Kitler,et al.  European Respiratory Society , 2005, International Journal of Pharmaceutical Medicine.

[28]  C. Wainwright,et al.  Sensitivity of respiratory bacteria to lignocaine , 2005, Pathology.

[29]  Janet Stocks,et al.  Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. , 2005, American journal of respiratory and critical care medicine.

[30]  G L Hall,et al.  Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation , 2005, Thorax.

[31]  J. Stocks,et al.  Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis , 2004, Thorax.

[32]  G. Laurent,et al.  Getting grant applications funded: lessons from the past and advice for the future , 2004, Thorax.

[33]  P. Gustafsson,et al.  Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis , 2003, European Respiratory Journal.

[34]  P. Farrell,et al.  Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis , 2003, Pediatric pulmonology.

[35]  C. Wainwright,et al.  Cost of delayed childbearing , 2002, Archives of disease in childhood.

[36]  R. Henry,et al.  Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[37]  A. Wade,et al.  Airway function in infants newly diagnosed with cystic fibrosis , 2001, The Lancet.

[38]  G. Campbell,et al.  Antimicrobial effects of lidocaine in bronchoalveolar lavage fluid. , 2000, The Journal of antimicrobial chemotherapy.

[39]  J. Emerson,et al.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis , 1999, Pediatric pulmonology.

[40]  Maya Ramagopal,et al.  High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate , 1999, Pediatric Radiology.

[41]  N. Rosenthal,et al.  Regional variability of lung inflammation in cystic fibrosis. , 1997, American journal of respiratory and critical care medicine.

[42]  N. Høiby,et al.  Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis , 1997, Pediatric pulmonology.

[43]  J. Carlin,et al.  Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis , 1996, Pediatric pulmonology.

[44]  T. Sandstrom,et al.  Bronchoalveolar lavage studies in children without parenchymal lung disease: Cellular constituents and protein levels , 1995, Pediatric pulmonology.

[45]  P. Phelan,et al.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.

[46]  C. Gaultier,et al.  Respiratory function measurements in infants: measurement conditions. Working Group of the European Respiratory Society and the American Thoracic Society. , 1995, The European respiratory journal.

[47]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[48]  M. Brendel,et al.  Differential cytology of bronchoalveolar lavage fluid in normal children. , 1994, The European respiratory journal.

[49]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[50]  J. Peters,et al.  Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study. , 1980, AJR. American journal of roentgenology.

[51]  P. Aurora.  Multiple-breath washout in preschool children--FRC and ventilation inhomogeneity. , 2006, Paediatric respiratory reviews.

[52]  A. Chrispin,et al.  The systematic evaluation of the chest radiograph in cystic fibrosis , 2005, Pediatric Radiology.

[53]  A. Clément,et al.  Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. , 2000 .

[54]  F. Ratjen,et al.  ERS Task Force on bronchoalveolar lavage in children Members of the Task Force: J. de Blic and F. Midulla (co-chairmen), A. Barbato, A. Clement, I. Dab, , 2000 .

[55]  Janet Stocks,et al.  Infant respiratory function testing , 1996 .

[56]  C. Gaultier.  Respiratory muscle function in infants. , 1995, The European respiratory journal.

[57]  American Academy of Pediatrics Committee on Drugs and Committee on Environmental Health: Use of chloral hydrate for sedation in children. , 1993, Pediatrics.